NCP
>
Multiple Sclerosis
> In the News
4/div>
In the News
<`3>Recent Intervaews and Articles
Gut Microbes May Influence Multiple Sclerosis Progression
Researchers at UCSF have identified specific gut eicrobes associated with multiple sclerosis in human patients, afd show that these microbes take part in regulating immufe responses in eouse models of the disease.
By Nicholas Weiler for UCSF on September 11, 2017
Virtual Clinical Trials: Getting the Whole Picture in MS
Featuring results from UCSF's own FITRiMS study, the article sheds light on how virtual visits using remote technologies and devices can help improve access, enrollment, diversity, and even the quality of data gathered in clinical trials.
By Sarah Owens for Neurology Today on September 7, 2017
Next-Gen Precision Diagnostics Now Available at UCSF
Now made available through the UCSF Center for Next-Gen Precision Diagnostics (NGDx), a new and exciting single test can distinguish among a vast range of infections.
By Laura Kurtzman for UCSF on July 13, 2017
DNA test hailed as an advance over standard procedures for diagnosing brain infections
Pioneered by UCSF Drs. Michael Wilson, Joseph DeRisi, and Charles Chiu, a groundbreaking new DNA test is helping to diagnose otherwise elusive and previously-undectable infections of the brain.
By Kat McGowan for Scientific American on June 22, 2017
Managing Pregnancy When You Have MS
Dr. Riley Bove, alongside doctors from other institutions, discuss ways to help women manage pregnancy while having MS.
By Heidi Godman for US News & World Report on June 16, 2017
How to Choose the Right Assistive Walking Device When You Have MS
Dr. Riley Bove, alongside doctors from other institutions, offer their insight on the changing landscape of MS disability progression, and discuss appropriate ways to navigate and consider the various assistive devise options.
By Heidi Godman for US News & World Report on May 19, 2017
After 40-year odyssey, first drug for aggressive MS wins FDA approval
Following the highly anticipated FDA approval of the MS drug Ocrelizumab (Ocrevus), explore the enduring, and at times uncertain path leading to it's creation.
By Ron Winslow for STAT News on March 28, 2017
Facebook Live Q&A with Neurologist & MS Expert, Dr. Sherman Jia
Join us on Thursday, March 30th from 5-6PM (PDT) to watch Dr. Sherman Jia, one of our promising Fellows, field questions live on Healthline!
Positive Multiple Sclerosis Clinical Trial Results Support New Treatment Approach
Dr. Stephen L. Hauser, alongside the highly anticipated publication of Phase III trial results, explains the ‘unprecedented’ effects of Ocrevus on the relapsing form of MS.
By Pete Farley on December 21, 2016
Think Like a Doctor: The Painter’s Headaches
Follow along with neuroimmunology expert Dr. Jeffrey Gelfand as he works to solve this case.
By Lisa Sanders, MD on November 3, 2016
California-wide initiative to bring precision medicine to patients
Dr. Riley Bove and the MS BioScreen: “Making it work”, in partnership with Sutter Healthcare and the National MS Society.
California Initiative to Advance Precision Medicine, 2016
Promoting remyelination in MS treatment
Our Medical Director Dr. Ari Green, focuses on the visual system.
Multiple Sclerosis Resource Centre, 2016
The new Weill Institute for Neurosciences: Building the Brain Clinics of the Future
Dr. Riley Bove teams up with Doctors from other Neurology and Psychiatry groups across the new
UCSF Weill Institute for Neurosciences to reimagine clinical care.
UCSF Weill Institute for Neurosciences on October 27, 2016
In children with MS, a “vitamin D genetic risk score” may predict relapses
Pediatric MS Drs. Graves and Waubant present data from the International Pediatric MS Network.
By Brian Hoyle on October 18, 2016
How does MS change as women move towards menopause and beyond?
Dr. Riley Bove’s research to date has focused on shedding light on the menopausal transition in women with MS. She is currently leading a
hormone trial.
How Does Menopause Affect Women With MS?
By Alisa Woods, PhD on June 16, 2016
The Latest News On MS And Hormones – MCP’s Empowered By Dr. Riley Bove
By Kate Milliken on July 26, 2016
The bacteria that live in our guts may shape our risk of developing immune disease
UCSF researcher Dr. Sergio Baranzini is leading an international study to find the culprits.
Baranzini Lab, UCSF on April 22, 2016
Aging Ovaries May Signal Imminent Progression of MS
Drs. Graves and Oksenberg report that declines in levels of anti-mullerian hormone (AMH), a measure of ovarian reserve, may predict brain volume loss.
By Caroline Helwick on February 22, 2016
News Archives
2015 Society Leadership Conference Research Panel
Dr. Ari Green and other leading MS researchers discuss recent topics at the 2015 Society Leadership Conference in Fort Worth, TX.
NMSS on Nov 17, 2015
An exciting update to the B cell story
Dr. Stephen Hauser discusses the promising future for B cell therapies.
By Erin Biba on Oct 8, 2015
Next-Gen Genomic Tests Identify Brain-Eating Amoeba
New UCSF Center Aims to Make Tests More Affordable and Accessible to Doctors.
By Nicholas Weiler on September 8, 2015
New Center Will Advance Life-Saving Genome-Based Diagnostic Tools
UCSF-Designed Tests Pinpoint Rare Infectious Agents Far More Rapidly Than Conventional Methods
By Pete Farley on August 20, 2015
Learning About Neuroprotection for Multiple Sclerosis Treatment
Q&A With Dr. Emmanuelle Waubant
MD Magazine on Apr 29, 2015
Potential new therapeutics and the influence of diet
Interview with Dr. Emmanuelle Waubant on potential new therapeutics and the influence of diet.
Multiple Sclerosis Resource Centre, 2015
Striking a Nerve: Allergy Drug Tested for MS
Ari Green, MD and Jonah Chan, PhD launch a clinical trial to evaluate the active ingredient in Tavist as a possible remyelinating agent for patients with multiple sclerosis.
John Gever for MedPage Today February 06, 2014
What to know about clinical trials and MS
Q & A with Dr. Emmanuelle Waubant
JHo Editor February 04, 2014
Barancik Prize winner aims for myelin repair
Jonah Chan, PhD, focuses on the potential of existing drugs to repair myelin.
Vicky Uhland for NMSS Momentum Magazine, 2014
Multiple Sclerosis: Five sources to seek after diagnosis
Dr. Elizabeth Crabtree and the UCSF MS Center support group were recognized as a top resource in the Bay Area by the San Jose Mercury News after a diagnosis of MS.
By Jessica Yadegaran on 05/13/2013
Nutrition and MS
Dr. Elizabeth Crabtree discusses nutrition and its impact on MS.
Sorop Sounding Board on Apr 17, 2013
UCSF Neurologist Wins Top International Prize for Multiple Sclerosis Research
Stephen Hauser Receives Lifetime Achievement Award
April 05, 2013
Scientists Identify Key Biological Mechanism in Multiple Sclerosis
Imaging Study Finds Potential New Target to Combat Disease
By Anne Holden on November 30, 2012
Pictures from Pediatric MS Family Day
Center Without Walls Research Project - Emmanuelle Waubant, MD, PhD - UCSF
Meet Dr. Emmanuelle Waubant, Associate Professor of Neurology, Director Regional Pediatric MS Center at UCSF, and Director of the Nancy Davis Center Without Walls program. Here is an overview of her latest research - Pediatric MS.
UC San Francisco tests new class of MS drugs
Advances in MRI technology and cellular engineering are giving new hope to people fighting Multiple sclerosis. SmartPlanet visits the University of California at San Francisco and talks to Dr. Emannuelle Waubant about new drug therapy that is reducing brain lesions and cutting down on relapse for patients.
Charlie Rose Brain Series 2, Episode 9: Multiple Sclerosis
Dr. Stephen Hauser and colleagues talk about the current state of MS research and treatment interventions.
Vitamin D
Dr. Stephen Hauser talks about Vitamin D with regard to multiple sclerosis.
A GWAS Gets Into Shape
Researchers connect gene variants to structure of brain lesions
By Mitch Leslie on 14 Feb 2013